InvestSMART

Cochlear Limited (ASX: COH) - Announcements

Current share price for COH : $142.740 1.77 (1.26%)+

ASX company news and announcements for Cochlear Limited (COH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cochlear Limited (COH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cochlear Limited (COH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cochlear Limited (COH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$9,335 Dividend/Distribution - COH 16 Aug 2019 8:25AM $201.520 $142.740 fallen by 29.17%
$9,335 Appendix 4E 16 Aug 2019 8:25AM $201.520 $142.740 fallen by 29.17%
$9,335 Becoming a substantial holder 29 Jul 2019 5:53PM $223.960 $142.740 fallen by 36.27%
$9,335 Ceasing to be a substantial holder - amended 16 Jul 2019 4:13PM $221.280 $142.740 fallen by 35.49%
$9,335 Ceasing to be a substantial holder 15 Jul 2019 4:19PM $220.380 $142.740 fallen by 35.23%
$9,335 COH - Profile Plus FDA Approval 17 Jun 2019 8:40AM $204.230 $142.740 fallen by 30.11%
$9,335 COH Hosts Capital Markets Day 10 May 2019 10 May 2019 8:22AM $193.720 $142.740 fallen by 26.32%
$9,335 Cochlear announces launch of Nucleus Profile Plus implant 16 Apr 2019 8:45AM $167.590 $142.740 fallen by 14.83%
$9,335 UK cochlear implant criteria change 8 Mar 2019 9:04AM $177.140 $142.740 fallen by 19.42%
$9,335 Becoming a substantial holder from PNI 5 Mar 2019 4:57PM $173.500 $142.740 fallen by 17.73%
$9,335 Becoming a substantial holder 4 Mar 2019 6:38PM $173.850 $142.740 fallen by 17.89%
$9,335 Change of Director's Interest Notice 4 Mar 2019 8:55AM $172.920 $142.740 fallen by 17.45%
$9,335 COH Half Year Results Analyst - 19.02.2019 19 Feb 2019 8:35AM $194.410 $142.740 fallen by 26.58%
$9,335 COH Half Year Results Media Release - 19.02.2019 19 Feb 2019 8:34AM $194.410 $142.740 fallen by 26.58%
$9,335 Dividend/Distribution - COH 19 Feb 2019 8:32AM $194.410 $142.740 fallen by 26.58%
$9,335 Half Yearly Report and Accounts 19 Feb 2019 8:32AM $194.410 $142.740 fallen by 26.58%
$9,335 Appendix 3B 11 Jan 2019 9:40AM $184.670 $142.740 fallen by 22.71%
$9,335 Becoming a substantial holder 27 Nov 2018 8:23AM $166.830 $142.740 fallen by 14.44%
$9,335 Initial Director's Interest Notice - Appendix 3X S A Hussain 22 Nov 2018 12:56PM $167.020 $142.740 fallen by 14.54%
$9,335 Ceasing to be a substantial holder 22 Nov 2018 8:30AM $162.660 $142.740 fallen by 12.25%
$9,335 Becoming a substantial holder 21 Nov 2018 8:30AM $158.740 $142.740 fallen by 10.08%
$9,335 Appointment of Abbas Hussain to Cochlear Limited Board 20 Nov 2018 9:14AM $158.740 $142.740 fallen by 10.08%
$9,335 Appendix 3Y - Diggory Howitt 14 Nov 2018 9:54AM $168.020 $142.740 fallen by 15.05%
$9,335 COH Invest in Nyxoah 13 Nov 2018 8:49AM $175.450 $142.740 fallen by 18.64%
$9,335 Appendix 3B 12 Nov 2018 10:56AM $175.180 $142.740 fallen by 18.52%

651 - 675 of 930 results

Page 27 of 38

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.